Table 2 Adverse events of Cardiorenal type 1 patients according to allocation groups during the study period
All patients, n = 80 | Stepped Furosemide, n = 40 | Combined Diuretics n = 40 | p value | |
|---|---|---|---|---|
Any adverse event (%) | 68 (85) | 35 (7.5) | 33 (82.5) | 0.53 |
Metabolic alkalosis (%) | 24 (30) | 12 (30) | 12 (30) | 0.60 |
Hypokalemia (%) | 15 (18.8) | 8 (20) | 7 (17.5) | 0.78 |
Hyponatremia (%) | 36 (45) | 18 (45) | 18 (45) | 1.0 |
Hypotension (%) | 5 (6.2) | 4 (10) | 1 (2.5) | 0.35 |